We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$99.8B
1-Year Est. Return
45.22%
This Fund
S&P 500
This Quarter
Est. Return
+28.59%
1 Year Est. Return
+45.22%
3 Year Est. Return
+121.82%
5 Year Est. Return
+143.39%
10 Year Est. Return
+531.52%
AUM
$99.8B
AUM Growth
+$13.6B
(+16%)
Cap. Flow
-$1.26B
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
2,371
New
96
Increased
771
Reduced
1,260
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$319M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$239M |
| 3 |
Synopsys
SNPS
|
+$203M |
| 4 |
KLA
KLAC
|
+$146M |
| 5 |
FedEx
FDX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$538M |
| 2 |
Lam Research
LRCX
|
+$289M |
| 3 |
Procter & Gamble
PG
|
+$275M |
| 4 |
Intel
INTC
|
+$215M |
| 5 |
Micron Technology
MU
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.14% |
| 2 | Healthcare | 12.04% |
| 3 | Financials | 9.88% |
| 4 | Consumer Discretionary | 8.82% |
| 5 | Industrials | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Gentex
GNTX
$4.93B
| $82K | ﹤0.01% |
3,244
+427
| +15% | +$10.1K |
|
|
SARO
1527
StandardAero Inc
SARO
$9.06B
| $81.5K | ﹤0.01% |
2,726
+244
| +10% | +$6.42K |
|
1528
Bio-Rad Laboratories Class A
BIO
$9.68B
| $81.3K | ﹤0.01% |
277
-44
| -14% | -$12.5K |
|
1529
Eastern Bankshares
EBC
$5.34B
| $81.1K | ﹤0.01% |
3,646
-171
| -4% | -$3.47K |
|
|
DFTX
1530
Definium Therapeutics
DFTX
$5.9B
| $80.5K | ﹤0.01% |
1,711
-101
| -6% | -$2.5K |
|
1531
Spyre Therapeutics
SYRE
$8.98B
| $79.6K | ﹤0.01% |
897
+9
| +1% | +$657 |
|
1532
Helmerich & Payne
HP
$4.29B
| $79K | ﹤0.01% |
2,414
-114
| -5% | -$4.27K |
|
1533
MDU Resources
MDU
$4.27B
| $78.9K | ﹤0.01% |
3,722
-3,450
| -48% | -$75K |
|
1534
Vail Resorts
MTN
$5.29B
| $78.6K | ﹤0.01% |
577
-10
| -2% | -$1.3K |
|
1535
Box
BOX
$4.48B
| $78.4K | ﹤0.01% |
2,953
-812
| -22% | -$20.3K |
|
1536
Expro Ltd
XPRO
$2.07B
| $77.9K | ﹤0.01% |
5,277
+796
| +18% | +$12.8K |
|
1537
Leonardo DRS
DRS
$11.9B
| $77.7K | ﹤0.01% |
1,820
-371
| -17% | -$16.5K |
|
1538
KB Home
KBH
$3.42B
| $77.1K | ﹤0.01% |
1,232
-73
| -6% | -$3.8K |
|
1539
Louisiana-Pacific
LPX
$5.15B
| $77.1K | ﹤0.01% |
980
-201
| -17% | -$14.8K |
|
1540
Riley Exploration Permian
REPX
$796M
| $76.9K | ﹤0.01% |
2,333
+441
| +23% | +$15.7K |
|
1541
Saic
SAIC
$5.35B
| $76.8K | ﹤0.01% |
696
-75
| -10% | -$7.59K |
|
1542
Grupo Aeroportuario del Pacifico
PAC
$12.4B
| $76.7K | ﹤0.01% |
303
-100
| -25% | -$24.6K |
|
1543
Laureate Education
LAUR
$5.1B
| $75.8K | ﹤0.01% |
2,088
-352
| -14% | -$11.9K |
|
1544
H.B. Fuller
FUL
$3.24B
| $75.8K | ﹤0.01% |
1,301
+100
| +8% | +$6.15K |
|
1545
Brady Corp
BRC
$4.48B
| $75.7K | ﹤0.01% |
827
+116
| +16% | +$9.64K |
|
1546
Clear Secure
YOU
$4.7B
| $75.3K | ﹤0.01% |
1,352
-74
| -5% | -$4.05K |
|
1547
Extreme Networks
EXTR
$3.2B
| $75.3K | ﹤0.01% |
2,325
-1,208
| -34% | -$29.1K |
|
1548
Apogee Therapeutics
APGE
$10.2B
| $75.3K | ﹤0.01% |
567
-53,870
| -99% | -$4.85M |
|
1549
Celsius Holdings
CELH
$7.28B
| $75.2K | ﹤0.01% |
2,568
-125
| -5% | -$3.94K |
|
1550
Travere Therapeutics
TVTX
$5.86B
| $75.1K | ﹤0.01% |
1,322
-68
| -5% | -$3.02K |
|
Similar funds
BNP Paribas Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, BNP Paribas Asset Management held 2,371 positions worth $99.8B, up 16% from $86.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management's Q2 2026 filing shows 96 new, 771 increased, 1,260 reduced and 181 closed positions. Its largest new stake was Alphabet Inc Depositary Shares Series A Preferred Stock: 1,875,000 shares worth $1.89M. The largest sale was Advanced Micro Devices, an estimated $538M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
- BNP Paribas Asset Management's largest Q2 2026 buy was Alphabet Inc Depositary Shares Series A Preferred Stock: 1,875,000 shares worth $1.89M.
- BNP Paribas Asset Management added most to Microsoft in Q2 2026, an estimated $319M increase.
- BNP Paribas Asset Management's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $538M.
- BNP Paribas Asset Management fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $27.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $99.8B portfolio in Q2 2026.
- BNP Paribas Asset Management opened 96 new positions and closed 181 in Q2 2026.
- BNP Paribas Asset Management's portfolio value rose 16% quarter-over-quarter to $99.8B.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.